Page last updated: 2024-08-23

1-deoxynojirimycin and Hepatitis B, Chronic

1-deoxynojirimycin has been researched along with Hepatitis B, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Block, TM; Blumberg, BS; Dwek, RA; Ebling, M; Jacob, GS; Korba, B; Lansky, DM; Lu, X; Mehta, AS; Tennant, B1

Trials

1 trial(s) available for 1-deoxynojirimycin and Hepatitis B, Chronic

ArticleYear
Treatment of chronic hepadnavirus infection in a woodchuck animal model with an inhibitor of protein folding and trafficking.
    Nature medicine, 1998, Volume: 4, Issue:5

    Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Biological Transport; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Glucosides; Glycoside Hydrolase Inhibitors; Glycosylation; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Mannosides; Marmota; Oligosaccharides; Protein Folding; Rodent Diseases; Virus Replication

1998